缅北禁地

Current Positions

Director of National Poisons Information Service (缅北禁地) and UK Teratology Information Service, September 2019-

Consultant Physician and Clinical Toxicologist, 缅北禁地 Hospitals NHS Foundation Trust, April 2009-

Honorary Clinical Senior Lecturer, 缅北禁地, April 2009-

Honorary Consultant Clinical Toxicologist, UK Health Security Agency

Academic Qualifications and Professional Affiliations

MBBS 2nd Class Honours with Distinction, 缅北禁地, UK, 1995

Doctor of Medicine (MD), 缅北禁地, UK, 2005. Thesis: Factors affecting cardiac repolarisation in recipients of thioridazine. Supervisors: Prof S Thomas and Prof A Daly

Postgraduate Certificate in Medical Education, 缅北禁地, 2016

Membership of Royal College of Physicians MRCP (UK), 1998   

Certificate of Completion of Specialist Training (CCST) in General Internal Medicine and Clinical Pharmacology, 2005

Fellow, Royal College of Physicians (Edinburgh), 2007

Fellow, Royal College of Physicians (London), 2013

Fellow, European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 2025

Member, British Pharmacology Society

Member, European Society of Medicine

Awards/Prizes

National Clinical Impact Award Level 1 2022-27

Wiley British Journal of Clinical Pharmacology Editors Performance Awards 2022 and 2025  

Esteem Indicators

Member British Pharmacopoeia Commission Herbal and Complementary Medicines Expert Advisory Group 2023-

External Examiner, Diploma/Masters in Medical Toxicology, Cardiff University 2023-

External Examiner, MSc in Experimental and Translational Therapeutics, Oxford University 2023-

External Clinical Adviser, Health Service Ombudsman 2021-

Executive Editor, British Journal of Clinical Pharmacology 2021-

Co-Editor Poisoning issue, Medicine 2020 and 2024

NPIS CPD Director, 2017-2021

NPIS/Royal College of Pathologists/RCEM Lab Assay Working Group 2024

NPIS/Royal College of Emergency Medicine Antidote Guideline working group

Invited Member, Toxicology Specialist Interest Group, Royal College of Emergency Medicine 2024-

EAPCCT Member, Paracetamol (acetaminophen) poisoning clinical toxicology recommendations international collaborative group 2024-

Clinical Toxicology Expert Advisor to WHO to produce and update training material on laboratory investigation of chemical incidents and TPP Development Group for detection of diethylene glycol/ethylene glycol in contaminated medicines 2025 

Board member European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 2022-2024

Clinical Lead, Yellow Card Centre (Northern & Yorkshire)

Medical Director, Regional Drugs and Therapeutics Centre, 缅北禁地-upon-Tyne 2019-2025

Member of MHRA ISAC (Independent Scientific and Advisory Committee) 2007-2014

Member of MHRA PEAG (Pharmacovigilance Expert Advisory Group) 2011- 2023

Member Paracetamol expert working group, European Medicines Agency 2017

Member MRCP UK Part 1 Standard-setting Group 2023-

Member MRCP UK Part 1 Specialty Question-Writing Group Clinical Pharmacology & Therapeutics 2007-2015

Member MRCP UK Part 1 Exam Board 2015-2022 

Chief External Examiner, Brighton & Sussex Medical School 2018-2022

Faculty of Medical Sciences Ethics Committee, 缅北禁地 2010-2018

Invited Lectures at International Conferences/Congresses

EUSEM Congress, Vienna, Austria, October 2025. Novel benzodiazepines

Global Health Safety Initiative. Enhancing Public Health Management of Chemical Incidents through Collaboration with Poison Centres: a Case Studies Based Virtual Symposium Feb 2025. Shedding light on DNP poisoning in the UK: progress and challenges encountered.

MENATOX Congress, Feb 2025, Muscat, Oman. L-carnitine and carbapenem for valproic acid-induced toxicity.

APAMT Congress, November 2024, Penang, Malaysia. Novel benzodiazepines.

TAPNA Conference, May 2024, Melbourne, Australia. L-carnitine and meropenem for valproic acid overdose: uncovering the evidence?

TAPNA Conference, May 2024, Melbourne, Australia. Cobinamide and other novel cyanide antidotes.

MENATOX Congress, Feb 2024, Abu Dhabi, UAE. The SNAP protocol for paracetamol poisoning.

Belgium-Luxembourg Toxicology Society conference, October 2023, Oostduinkerke, Belgium. Paracetamol intoxication and the SNAP protocol.

EAPCCT International Congress, Palma, Mallorca May 2023. Acetaminophen in pregnancy: is it dangerous?

EUSEM Congress, Berlin, Germany October 2022. Paracetamol poisoning. Is SNAP the new black. How about fomepizole?

NACCT International Congress, Boston, US September 2016. Valproate overdose: what is the role of L-carnitine.

EAPCCT XXXVI International Congress, Madrid, Spain May 2016. Valproate overdose: what is the role of L-carnitine.

NACCT International Congress, Atlanta, US October 2013. Implications for acetylcysteine dosing regimen following results of the UK SNAP trial.

EAPCCT XXXIII International Congress, Copenhagen, Denmark May 2013. Clinical Toxicology of Ayurvedic Medicines.

EAPCCT XXXI International Congress, Dubrovnik, Croatia, May 2011.The pharmacology of drug delivery.

ESF EMRC Exploratory Workshop: Multidisciplinary consortium for the development of effective, but non-toxic drugs against MDRTB and XDR-TB. Lisbon, Portugal, 30 November – 4 December 2010. Clinical Trials using thioridazine for XDR-TB.

EAPCCT XXX International Congress, Bordeaux, May 2010. What is the evidence for Added benefit from Hemoperfusion? Con

EAPCCT XXVIII International Congress, Seville, May 2008. Clinical Toxicology of Ayurvedic Medicines.

Invited Lectures at National congresses

RSM From COVID to Clinical Emergency Medicine Webinar, June 2022. Paracetamol overdose and the SNAP protocol

RCEM Congress, March 2022, Bournemouth. What’s new in Emergency medicine toxicology?

RCEM Congress, March 2023, London. Management of Digoxin Toxicity

RCEM Congress, October 2024, Gateshead. Guidelines in management of opioid overdose.

Current Teaching Contribution:

Strand Lead, MRes Translational Medicine and Therapeutics Programme

Module Leader, MRes Experimental Medicine and Therapeutics MMB8005

Lecturer, MRes Drug Discovery & Development MMB8006

Lecturer, BSc Pharmacology, Advanced Pharmacogenetics PED3005

Lecturer, BSc Pharmacology, Drug Discovery & Development PED3007

Previous Teaching contribution:

Course Director, Clinical Pharmacology & Therapeutics course, Stage 4 MBBS 2015-2020

Module Leader, Clinical Drug Development, MSc Clinical and Health Sciences, 缅北禁地 2015-2017

Module Leader, Diploma in Therapeutics, 缅北禁地, 2010-2013

Lecturer, Diploma in Clinical Research MCR8008

Lecturer, MRes Toxicology module MMB8032

Teaching projects contributor:

Development of a vertical Clinical Pharmacology & Therapeutics strand in the 缅北禁地 MBBS course using the British Pharmacological Society core curriculum for medical students

Development of key learning outcomes for Clinical Pharmacology & Therapeutics teaching in Europe as part of an Education Working Group of the European Association of Clinical Pharmacology &Therapeutics and its affilitated Network of Teachers in Pharmacotherapy (NOTIP)

Erasmus EU-funded project to develop a Diploma in Clinical Toxicology at Cairo University with 缅北禁地 and University of Malta as collaborators.

Global Public Health project funded by the Overseas Development Agency to train staff in low-income countries and provide assistance with poisons centre set up and development. I participated in 2 training missions in Addis Ababa, Ethiopia 2018 and Yangon, Myanmar 2020.

WikiTox, a web-based Clinical Toxicology Teaching Resource Project (http://curriculum.toxicology.wikispaces.net/) set up following a WHO workshop to develop and deliver a curriculum in clinical toxicology for low-income countries.

Esteem Indicators:

External Examiner, Diploma/Masters in Medical Toxicology, Cardiff University 2023-

External Examiner, MSc in Experimental and Translational Therapeutics, Oxford University 2023-

Member MRCP (UK) Part 1 Standard-setting Group 2023-

Member MRCP (UK) Part 1 Exam Board 2015-2022 

Member MRCP (UK) Part 1 Specialty Question-Writing Group Clinical Pharmacology & Therapeutics 2007-2015

Question Writer, BPS/MSC Prescribing Skills Assessment (PSA)

Chief External Examiner, MBBS, Therapeutics, Brighton & Sussex Medical School 2018-2022

National CPD Director, UK National Poisons Information Service (NPIS) 2016-2020

Co-organiser, RCEM/NPIS Toxicology Study Days 2023, 2024

Invited Talks at National Study Days

West Midlands Acute Medicine conference, Birmingham, June 2018. Optimisation of acetylcysteine regimen: a 12-hour acetylcysteine (SNAP) protocol 

Acute and General Medicine Conference, October 2024, EXcel conference centre, London. Update on Management of Paracetamol overdose

RCEM Toxicology update, November 2019. Arrhythmias in poisoning

RCEM Toxicology update, June 2023. Paracetamol poisoning: SNAP update

RCEM Toxicology update, September 2025. Cardiotoxins

Medical Toxicology 2-Day Course, Cardiff, October 2018. Optimisation of acetylcysteine regimen: a 12-hour acetylcysteine (SNAP) protocol 

Medical Toxicology 2-Day Course, Cardiff, October 2025. Digoxin Toxicity and use of DigiFab: how much and when?

NPIS CPD Day, January 2006, 缅北禁地. Management of hypotension and arrhythmias in tricyclic poisoning

NPIS CPD Day, June 2006, Edinburgh. Paracetamol calls referred to consultants: 1 year experience

NPIS CPD Day, April 2007, 缅北禁地. Valproic acid toxicity: Controversies in management

NPIS CPD Day, October 2007, Edinburgh. BAEM/NPIS Antidote guidelines

NPIS CPD Day, February 2008, Cardiff. Gamma-hydroxybutyric acid

NPIS CPD Day, November 2008, Edinburgh. SNAP- a new approach to paracetamol poisoning

NPIS CPD Day, October 2009, 缅北禁地. Ecstasy- case report and management

NPIS CPD Day, November 2011, Edinburgh. Scorpion Stings

NPIS CPD Day, November 2011, Edinburgh. National Antidote audit

NPIS CPD Day, November 2013, 缅北禁地. Toxic Alcohol study

NPIS CPD Day, November 2014, Cardiff. Whole Bowel Irrigation update

NPIS CPD Day, November 2015, 缅北禁地. Acetylcysteine treatment for paracetamol overdose: what does the future really hold?

NPIS CPD Day, November 2016, 缅北禁地. Valproate overdose: what is the role of L-carnitine?

NPIS CPD Day, November 2017, 缅北禁地. SNAP- the nuts and bolts of a 12 hour acetylcysteine regimen.

NPIS CPD Day, March 2018, Birmingham. A medley of heavy metal cases.

NPIS CPD Day, September 2018, Edinburgh. NAC effect on INR

NPIS CPD Day, January 2021, Webinar. Tricyclic antidepressant poisoning

NPIS CPD Day, April 2025, 缅北禁地. Valproic acid overdose

NPIS CPD Day, October 2025, Cardiff. Digoxin antibodies for digoxin toxicity: how much and when? 

Research interests

1) Optimisation of antidote treatment for the management of poisoned patients

2) Pharmaco- and Toxico-vigilance

3) Epidemiology of poisoning

I led a national NPIS audit of antidote stocking in acute hospitals with showed huge variability in access to antidotes. This led to joint RCEM/NPIS guidelines on antidote availability for emergency departments in the UK and the setting up of 8 supra-regional antidote holding centres in England for category C rarely used antidotes.

I led a national study of patients treated with toxic alcohol poisoning, sponsored by EusaPharma, which showed that ethanol treatment caused more adverse reactions and medication errors compared to fomepizole. Fomepizole has been recommended as the first line treatment for toxic alcohol poisoning. Engagement with Waymade Pharmaceuticals has led to a marketing authorisation for fomepizole being granted by MHRA for treatment of ethylene glycol poisoning in the UK in 2024.

I have also served on advisory boards to SERB Pharmaceuticals and advised on dosing regimens for digoxin-specific antibodies for digoxin poisoning and indications for glucarpidase for methotrexate poisoning. I have published reviews on the optimal dosing of naloxone for opioid overdose and L-carnitine for valproic acid-induced toxicity.

I have also contributed to toxico-surveillance studies for toxic chemicals such as dinitrophenol which led to its reclassification as a poison under the Poisons Act in October 2023.

Paracetamol overdose

My research aims to optimise acetylcysteine treatment regimens for paracetamol poisoning to reduce adverse reactions without compromising efficacy. I devised using pharmacokinetic modelling a shorter 12h acetylcysteine regimen which was compared to the usual 21h regimen in the Scottish and 缅北禁地 Anti-Emetic Pre-Treatment in Paracetamol Poisoning (SNAP) clinical trial. I was the Principal Investigator for the SNAP clinical trial in 缅北禁地 2010-2012. This showed the shorter 12h regimen of acetylcysteine reduced the incidence of vomiting and anaphylactoid reactions (Lancet 2013).

I subsequently devised a clinical SNAP protocol (Scottish and 缅北禁地 Acetylcysteine protocol) which was endorsed by NPIS and implemented in clinical practice in several hospitals in the UK. An audit of effectiveness compared to the conventional 21h acetylcysteine regimen showed that the SNAP protocol was as effective as the conventional 21h protocol and was associated with fewer adverse reactions.(EClinical Medicine 2019).

In May 2023, the Royal College of Emergency Medicine (RCEM), National Poisons Information Service (NPIS) and British Association for the study of the Liver (BASL) issued a joint position statement recommending the SNAP regimen as the standard of care for treatment of paracetamol overdose in the UK.

I am currently involved in an international collaborative group looking to perform systematic reviews to provide consensus definitions and recommendations for the management of paracetamol overdose and chair of the HiSNAP Trial Steering Committee.

PhD supervision and examining

PhD supervisor, 缅北禁地 2018-2022 (Amani Alrossies): Evaluation of a Shorter 12h Acetylcysteine Regimen & Development of a Simpler Acetylcysteine (SNAP) Protocol for the Treatment of Paracetamol Poisoning

PhD Progress Panel member and Internal Examiner 缅北禁地: Emma Kampouraki, Jonathan Richardson, Salah Aboheilaika

PhD External Examiner: Ingrid Berling (University of 缅北禁地, Australia)

Contribution to national guidelines and reports

Royal College of Emergency Medicine and National Poisons Information Service Guideline for the Management of Patients with Suspected but Unidentified Poisoning in the Emergency Department. April 2025

Royal College of Emergency Medicine and National Poisons Information Service Guideline for the Assessment and Management of Acute Opioid Toxicity in Adults in the Emergency Department. April 2024

Royal College of Emergency Medicine and National Poisons Information Service Guideline on Antidote Availability for Emergency Departments September 2023.

RCEM, NPIS and BASL. Use of the SNAP Regimen for the Treatment of Paracetamol Toxicity in adults and children. May 2023

Thanacoody R, Waring WS, Good AM, Bateman DN, Lynch-Farmery R, O’Moore E. Burden of disease -Poisoning. Report commissioned by the Health Protection Agency Sept 2005

• Articles

  • Gray L, Beddard M, Jones S, Begum A, Azhar NB, Deslandes P, Coulson J, Bradberry S, Sandilands EA, Thanacoody RH, Ivory MO. . British Journal of Clinical Pharmacology 2025, 91(6), 1727-1738.
  • Brooke N, Carter G, Jagpal P, Cook M, Jones S, Cole D, Harbon S, Donohoe E, Elamin M, Thanacoody R, Duarte-Davidson R. . Toxicology Research 2025, 14(6), tfaf177.
  • Williams H, Jagpal P, Sandilands E, Morrison E, Gray L, Thanacoody HKR, Beg E, Bradberry S, Ferner R. . British Journal of Clinical Pharmacology 2025, 91(11), 3114-3120.
  • Watt A, Caparrotta T, Bradberry S, Gray L, Thanacoody R, Jackson G, Sandilands EA. . Archives of Diseases in Childhood 2025, 110(9), 687-692.
  • Chiew AL, Wood DM, Cao D, Overberg A, Faber K, Wong A, Thanacoody R, Pomerleau AC, Gosselin S, Bhalla A, Lonati D, Bateman DN. . Clinical Toxicology 2025, 63, 343-347.
  • Kazi B, Gray L, Thanacoody HKR, Pucci M, Tuthill D. . Archives of Diseases in Childhood 2025. In Press.
  • Humphries C, Clarke E, Eddleston M, Gillings M, Irvine S, Keating L, Miell A, Milne L, Muir L, O'Brien R, Oatey K, Raman R, Thanacoody R, Tuck S, Weir CJ, Wood DM, Dear JW. . BMJ Open 2025, 15, e097432.
  • Moyns E, Looms J, Jagpal PS, Day R, Sandilands EA, Gray LA, Thanacoody RHK, Bradberry SM. . Toxicology Communications 2025, 9(1), 2524302.
  • Edwards EP, Gray LA, Elamin MEMO, Veiraiah A, Thanacoody RHK, Coulson JM. . Clinical Toxicology 2025, 63(3), 212-216.
  • Edwards EP, Patel S, Gray LA, Veiraiah A, Bradberry SM, Thanacoody RHK, Coulson JM. . Clinical Toxicology 2025, 63(6), 426-433.
  • King A, Thanacoody R. . Medicine 2024, 52(6), 330-333.
  • King A, Thanacoody R. . Medicine 2024, 52(6), 369-371.
  • Yard HE, Thompson JP, Gray L, Coulson JM, Bradberry SM, Sandilands E, Thanacoody R, Tuthill D. . Archives of Disease in Childhood 2024, 109, 894-897.
  • Vincent F, Thompson J, Gray L, Bradberry S, Sandilands E, Thanacoody R, Tuthill D. . Archives of Disease in Childhood 2024, 109(7), 582-585.
  • Blundell M, Gill R, Thanacoody R, Humphries C, Wood DM, Dargan PI. . Emergency Medicine Journal 2024, 41, 440-445.
  • Thanacoody R, Anderson M. . Medicine 2024, 52(6), 327-329.
  • Moyns EJ, Welby-Everard P, Karim NA, Thanacoody RHK. . Clinical Toxicology 2023, 61(2), 136-137.
  • Hughes BW, Gray LA, Bradberry SM, Sandilands EA, Thanacoody RH, Coulson JM. . Clinical Toxicology 2023, 61(6), 445-452.
  • Thanacoody HKR. . British Journal of Clinical Pharmacology 2023, 89, 39-42.
  • Beaulieu J, Roberts DM, Gosselin S, Hoffman RS, Lavergne V, Hovda KE, Megarbane B, Lung D, Thanacoody R, Ghannoum M. . Clinical Toxicology 2022, 60(7), 784-797.
  • Haden M, Wheatley N, Gray LA, Bradberry SM, Sandilands EA, Thanacoody RH, Coulson J. . Clinical Toxicology 2022, 60(9), 1051-1058.
  • Hondebrink L, Zammit M, Høgberg LCG, Hermanns-Clausen M, Lonati D, Faber K, Thanacoody R. . Clinical Toxicology 2022, 60(10), 1145-1155.
  • Gentile D, Adams R, Klatka M, Bradberry S, Gray L, Thanacoody R, Jackson G, Sandilands E. . Journal of Public Health 2022, 44(3), 565-574.
  • Jagpal PS, Williams HA, Eddleston M, Lalloo D, Warrell D, Sandilands EA, Thanacoody R, Gray L, Bradberry SM. . Clinical Toxicology 2022, 60(9), 1044-1050.
  • Lamb T, Stewart D, Warrell D, Lalloo D, Jagpal P, Jones D, Thanacoody R, Gray L, Eddleston M. . Clinical Toxicology 2021, 59(11), 992-1001.
  • Thanacoody R. . Medicine 2020, 48(3), 156-159.
  • Pettie JM, Caparrotta TM, Hunter RW, EMorrison EE, David M Wood DM, Dargan PI, Thanacoody RH, Thomas SHL, Elamin MEMO, Francis B, Webb DJ, Sandilands EA, Eddleston M, Dear JW. . EClinicalMedicine 2019, 11, 11-17.
  • Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA, EACPT and NOTIP. . Clinical Pharmacology & Therapeutics 2019, 104(2), 317-325.
  • Bailey GP, Rehman B, Wind K, Wood DM, Thanacoody R, Nash S, Archer JRH, Eddleston M, Thompson JP, Vale JA, Thomas SHL, Dargan PI. . European Journal of Hospital Pharmacy 2016, 23(3), 145-150.
  • Thanacoody HKR. . Medicine 2016, 44(2), 95-96.
  • Thanacoody HKR. . Medicine 2016, 44(3), 197-198.
  • Thanacoody HKR, Gilfillan C, Bradberry SM, Davies J, Jackson G, Vale JA, Thompson JP, Eddleston M, Thomas SHL. . Clinical Toxicology 2016, 54(2), 134-140.
  • Thanacoody R, Caravati EM, Troutman WG, Hojer J, Benson BE, Hoppu K, Erdman A, Bedry R, Megarbane B. . Clinical Toxicology 2015, 53(1), 5-12.
  • Kamour A, George N, Gwynette D, Cooper G, Lupton D, Eddleston M, Thompson JP, Vale JA, Thanacoody HK, Hill SL, Thomas SH. . Emergency Medicine Journal 2015, 32, 383-386.
  • Guilding C, Ball SG, Kennedy DJ, Thanacoody R. . pA2 Online: E Journal of the British Pharmacological Society 2015, 13(3).
  • Bateman DN, Dear JW, Thanacoody HKR, Thomas SHL, Eddleston M, Sandilands EA, Coyle J, Cooper JG, Rodriguez A, Butcher I, Lewis SC, Vliegenthart ADB, Veiraiah A, Webb DJ, Gray A. . The Lancet 2014, 383(9918), 697-704.
  • Kamour A, James D, Lupton DJ, Cooper G, Eddleston M, Vale A, Thompson JP, Thanacoody R, Hill SL, Thomas SHL. . Clinical Toxicology 2014, 52(10), 1025-1031.
  • Thanacoody HKR, Gray A, Dear JW, Coyle J, Sandilands EA, Webb DJ, Lewis S, Eddleston M, Thomas SHL, Bateman DN. . BMC Pharmacology and Toxicology 2013, 14(1), 20.
  • Hojer R, Troutman WG, Hoppu K, Erdman A, Benson BE, Megarbane B, Thanacoody R, Bedry R, Caravati EM. . Clinical Toxicology 2013, 51(3), 134-139.
  • Benson BE, Hoppu K, Troutman WG, Bedry R, Erdman A, Hojer J, Megarbane B, Thanacoody R, Caravati EM. . Clinical Toxicology 2013, 51(3), 140-146.
  • Thanacoody RH, Aldridge G, Laing W, Dargan PI, Nash S, Thompson JP, Vale A, Bateman N, Thomas S. . Emergency Medicine Journal 2013, 30(5), 393-396.
  • Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. . Hepatology 2013, 58(2), 777-787.
  • Pettie J, Dow M, Sandilands EA, Thanacoody HKR, Bateman DN. . Emergency Medicine Journal 2012, 29, 482-486.
  • Thanacoody HKR. . Recent Patents in Anti-Infective Drug Discovery 2011, 6(2), 92-98.
  • Thanacoody HKR, Jay J, Sherval J. . Scottish Medical Journal 2009, 54(1), 7-10.
  • Thanacoody R. . Clinical Toxicology 2009, 47(7), 609-616.
  • Thanacoody HKR. . BMJ Case Reports 2009, (9), bcr06.2009.1924.
  • Thanacoody HKR, Waring WS. . Clinical Medicine 2008, 8(1), 92-95.
  • Thanacoody HKR, Good AM, Waring WS, Bateman DN. . Emergency Medicine Journal 2008, 25(3), 140-143.
  • Thanacoody HKR. . British Journal of Clinical Pharmacology 2007, 64(5), 566-574.
  • Thanacoody HKR. . Medicine 2007, 35(10), 556-557.
  • Thanacoody HKR. . Adverse Drug Reaction Bulletin 2007, (243), 931-934.
  • Thanacoody HKR. . Medicine 2007, 35(11), 619-619.
  • Thanacoody RHK, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. . Clinical Pharmacology and Therapeutics 2007, 82(5), 555-565.
  • Salih ISM, Thanacoody RHK, McKay GA, Thomas SHL. . Clinical Pharmacology and Therapeutics 2007, 82(5), 548-554.
  • Thanacoody HKR. . Emergency Medicine Journal 2007, 24(9), 677-678.

• Book Chapters

  • Thanacoody HKR. . In: Hema Ketha and Uttam Garg, ed. Toxicology Cases for the Clinical and Forensic Laboratory. London: Academic Press, 2020, pp.239-242.
  • Thanacoody HKR. . In: Whittlesea C; Hodson K, ed. Clinical Pharmacy and Therapeutics. Amsterdam: Elsevier Health Sciences, 2018, pp.53-65.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.176-177.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.79-80.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.14-15.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.168-171.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.81-82.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.46-47.
  • Thanacoody HKR. . In: Bateman DN, Jefferson RD, Thomas SHL, Thompson JP, Vale JA, ed. Oxford Desk Reference Toxicology. Oxford University Press, 2014, pp.229-230.
  • Thanacoody HKR. . In: Walker, R.S., Whittlesea, C, ed. Clinical Pharmacy & Therapeutics. Edinburgh, UK: Churchill Livingstone, 2012, pp.50-61.

• Conference Proceedings (inc. Abstracts)

  • Gilfillan CM, Bradley S, Gray LA, Bradberry SM, Veiraiah A, Thanacoody RHK. . In: 45th Congress of European Association of Poison Centres and Clinical Toxicologists. 2025, Glasgow: Taylor & Francis Inc.
  • Donohoe E, Lee R, Gray LA, Veiraiah A, Thanacoody RHK. . In: 45th Congress of European Association of Poison Centres and Clinical Toxicologists. 2025, Glasgow: Taylor & Francis Inc.
  • Moonira TN, Bradberry SM, Gray LA, Veiraiah A, Thanacoody RHK. . In: 45th Congress of European Association of Poison Centres and Clinical Toxicologists. 2025, Glasgow: Taylor & Francis Inc.
  • Tierney DJ, Kisimbo K, Pitt E, Thanacoody RHK. . In: 45th Congress of European Association of Poison Centres and Clinical Toxicologists. 2025, Glasgow: Taylor & Francis Inc.
  • Gziut T, Thanacoody RHK, Hill SL, Wiltshire S, Logan I, Boxshall L. . In: 45th Congress of European Association of Poison Centres and Clinical Toxicologists. 2025, Glasgow: Taylor & Francis Inc.
  • Moyns E, Jagpal PS, Pucci M, Jutley G, Sandilands EA, Gray LA, Thanacoody RHK, Bradberry SM. . In: 44th Congress of European Association of Poison Centres and Clinical Toxicologists. 2024, Munich, Germany: Taylor & Francis Inc.
  • Eagling VA, Thanacoody RHK, Gray LA, Bradberry SM, Sandilands EA. . In: 44th Congress of European Association of Poison Centres and Clinical Toxicologists. 2024, Munich, Germany: Taylor & Francis Inc.
  • Thomas E, Bradberry SM, Sandilands EA, Thanacoody RH, Gray LA, Coulson JM. . In: 44th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2024, Munich: Taylor & Francis Inc.
  • McKinty A, Bradberry SM, Sandilands EA, Thanacoody RHK, Gray L, Coulson JM. . In: 43rd Congress of European Association of Poison Centres and Clinical Toxicologists. 2023, Palma, Mallorca: Taylor & Francis Inc.
  • Eagling VA, Thanacoody RHK, Gray LA, Bradberry SM, Sandilands EA. . In: 43rd Congress of European Association of Poison Centres and Clinical Toxicologists. 2023, Palma: Taylor & Francis Inc.
  • Eagling VA, Jackson G, Thanacoody RHK, Gray LA, Bradberry SM, Sandilands EA. . In: 42nd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2022, Tallinn: Taylor & Francis Inc.
  • Jackson G, Eagling V, Thanacoody R, Gray L, Bradberry S, Sandilands E. The use of antidote in the management of digoxin poisoning. 2022, Toxicological Sciences.
  • Pucci M, Moyns E, Jutley G, Crisp R, Sandilands E, Gray L, Thanacoody R, Bradberry S. . In: British Journal of Clinical Pharmacology. 2022, Wiley.
  • Eagling VA, Jackson G, Thanacoody RHK, Gray LA, Bradberry SM, Sandilands EA. Oral methotrexate poisoning reported to the UK National Poisons Information Service (NPIS). In: 42nd Congress of European Association of Poison Centres and Clinical Toxicologists. 2022, Tallinn.
  • Williams H, Jagpal P, Bradberry S, Sandilands EA, Gray LA, Thanacoody RHK. Fatal propranolol overdoses reported to the UK National Poisons Information (NPIS) over 5 years, 2017-2021. In: 42nd Congress of European Association of Poison Centres and Clinical Toxicologists. 2022, Tallinn: Clinical Toxicology.
  • Alrossies AS, Motohashi K, Wiltshire S, Hill SL, Thomas SHL, Thanacoody RHK. . In: 42nd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2022, Tallinn: Taylor & Francis Inc.
  • Eagling V, Jackson G, Klatka M, Thanacoody R, Gray L, Bradberry S, Sandilands E. Digoxin poisoning reported to the UK National Poisons Information Service (NPIS). 2022, Toxicological Sciences.
  • Alrossies AS, Ross J, Harnett J, Wood DM, Dargan PI, Thanacoody HKR. Efficacy of a 12h intravenous acetylcysteine (SNAP) regimen following single acute paracetamol overdose. 2020, Clinical Toxicology.
  • Alrossies AS, Thanacoody RHK, Harnett J. Derivation of a clinical decision rule allowing earlier discharge of patients with paracetamol poisoning after a shorter 12-hour acetylcysteine (SNAP) protocol. 2019, Clinical Toxicology.
  • Thanacoody HKR, Nijhout HF, Reed MC, Thomas SHL. . In: North American Congress of Clinical Toxicology. 2017, Vancouver: Taylor & Francis.
  • Thanacoody HKR, Nijhout HF, Reed MC, Thomas SHL. . In: North American Congress of Clinical Toxicology. 2017, Vancouver: Taylor & Francis.
  • Thanacoody HKR, Thomas SHL. . In: 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2016, Madrid Spain: Taylor and Francis.
  • Thanacoody HKR, Thomas SHL. . In: 36th Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2016, Madrid, Spain.
  • Thanacoody HKR, Nijhout FH, Reed MC, Thomas SHL. . In: 36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2016, Madrid, Spain: Taylor & Francis.
  • Kamour A, James D, Lupton DJ, Cooper G, Eddleston M, Vale JA, Thompson JP, Thanacoody RHK, Hill SL, Thomas SHL. . In: XXXIV International Congress of EAPCCT. 2014, Brussels, Belgium: Informa Healthcare.
  • Kamour A, Gwynnette D, George N, Cooper G, Lupton DJ, Eddleston M, Thompson JP, Vale JA, Thanacoody RHK, Hill S, Thomas SHL. . In: XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2014, Brussels, Belgium: Informa Healthcare.
  • Kamour A, James D, Spears R, Cooper G, Lupton DJ, Eddleston M, Thompson JP, Vale JA, Thanacoody RHK, Hill S, Thomas SHL. . In: XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2014, Brussels, Belgium: Informa Healthcare.
  • Elamin M, Thanacoody R. . In: International Congress of EAPCCT. 2013, Copenhagen, Denmark: Informa Healthcare.
  • Brown J, Thanacoody R. . In: XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2013, Copenhagen, Denmark: Informa Healthcare.
  • Dear JW, Antoine DJ, Starkey-Lewis P, Platt V, Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, Bateman DN, Goldring CE, Park BK. . In: XXXIII International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT). 2013, Copenhagen, Denmark: EAPCCT.
  • Thanacoody HKR. . In: International Congress of EAPCCT. 2013, Copenhagen, Denmark: Informa Healthcare.
  • Thanacoody HKR, Weatherall I, Davies J, Thomas SHL. Treatment of severe toxic alcohol and glycol poisoning in the UK. In: International Congress of EAPCCT. 2012, London.
  • Thanacoody HKR, Weatherall I, Davies J, Thomas SHL. Toxic Alcohol and glycol poisoning in the UK- a 12 month prospective follow-up study. In: International Congress of EAPCCT. 2012, London.
  • Thanacoody HKR, Aldridge G, Laing W, Nash S, Dargan PI, Vale JA, Bateman DN, Thompson JP, Thomas SHL. . In: International Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2012, London: Informa Healthcare.
  • Thanacoody HKR, Nash S, Vale JA, Bateman DN, Thompson JP, Dargan PI, Thomas SHL. . In: International Congress of the European Association of the Poisons Centres and Clinical Toxicologists. 2012, London, UK: Informa Healthcare.
  • Amaral L, Abbate E, Boeree M, Gillespie S, Thanacoody R, Udwadia Z, vanIngen J, vanSoolingen D, Viveiros M. . In: 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy. 2011, Milan, Italy.
  • Weatherall I, Thanacoody HKR, Davies J, Cooper G, Thomas SHL. . In: International Congress of the European Association of Poisons Centres and Clinical Toxicologists. 2011, Dubrovnik, Croatia: Informa Healthcare.
  • Pettie JM, Dow MA, Thanacoody HKR, Sandilands EA, Bateman DN. Integrated care pathway for the management of the paracetamol poisoned patient. In: XXX International Congress of EAPCCT. 2010, Bordeaux.
  • Thanacoody HKR. . In: EAPCCT XXVIII International Congress. 2008, Seville, Spain: Informa Healthcare.
  • Thanacoody HKR, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. . In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Thanacoody HKR, Daly AK, Reilly JG, Ferrier IN, Thomas SHL. . In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Salih I, Thanacoody HKR, McKay G, Thomas SHL. . In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.
  • Salih I, Thanacoody HKR, McKay G, Thomas SHL. . In: British Journal of Clinical Pharmacology: Meeting of the British Pharmacological Society Clinical Pharmacology Section. 2006, London, UK: Wiley-Blackwell Publishing Ltd.

• Editorials

  • Wood DM, Dear JW, Thanacoody R, Juurlink DN, Chiew AL, Dargan PI. . British Journal of Clinical Pharmacology 2025, 91(3), 593-594.
  • Dear JW, Dargan PI, Juurlink DN, Thanacoody RHK, Wood DM. . British Journal of Clinical Pharmacology 2022, 88(1), 56-57.

• Letters

  • Bateman DN, Dear JW, Thanacoody HKR, Thomas SHL, Eddleston M. . The Lancet 2014, 383(9926), 1383-1383.
  • Bateman DN, Thanacoody HK, Waring WS. . The Lancet 2006, 368(9551), 1962-1963.

• Note

  • Dear JW, Dargan PI, Eddleston M, Thanacoody RH, Thomas SHL. . EClinicalMedicine 2019, 14, 13-13.

• Online Publication

  • Thanacoody R. . BMJ Publishing Group, 2025. Available at: .

• Reviews

  • King A, Thanacoody RHK. . Medical Research Archives 2025, 13(10).
  • Gziut T, Thanacoody R. . British Journal of Clinical Pharmacology 2025, 91(3), 636-657.
  • Andrews P, Anseeuw K, Kotecha D, Lapostolle F, Thanacoody R. . European Journal of Emergency Medicine 2023, 30(6), 395-401.
  • Motohashi K, Thanacoody RH. . British Journal of Hospital Medicine 2022, 83(9), 1-16.
  • Thompson JP, Watson ID, Thanacoody HKR, Morley S, Thomas SHL, Eddleston M, Vale JA, Bateman DN, Krishna CV. . Annals of Clinical Biochemistry 2014, 51(3), 312-325.
  • Thanacoody HKR, Thomas SHL. . Toxicological Reviews 2005, 24(3), 205-214.
  • Bradberry SM, Thanacoody HKR, Watt BE, Thomas SHL, Vale JA. . Toxicological Reviews 2005, 24(3), 195-204.
  • Thanacoody HKR, Thomas SHL. . Clinical Medicine 2003, 3(2), 114-118.